drugset / Trial / NCT03828149
Evaluation of Safety and Pharmacodynamics of OP0201 Compared to Placebo in Healthy Adults
RandomizedCrossoverTriple-blindOther
Summary
Evaluation of Safety and Pharmacodynamics of OP0201 Compared to Placebo in Healthy Adults
Timeline
- Start
- 2019-02-08
- Primary completion
- 2019-03-07
- Completion
- 2019-03-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | OP0201 | Unknown | 20 mg | — |
Indications
No indication recorded.